Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 2 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: E9ANK7
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 5 |
GO:0006807 | nitrogen compound metabolic process | 2 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0019538 | protein metabolic process | 3 | 5 |
GO:0043170 | macromolecule metabolic process | 3 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0004177 | aminopeptidase activity | 5 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0008233 | peptidase activity | 3 | 5 |
GO:0008235 | metalloexopeptidase activity | 5 | 5 |
GO:0008237 | metallopeptidase activity | 4 | 5 |
GO:0008238 | exopeptidase activity | 4 | 5 |
GO:0016787 | hydrolase activity | 2 | 5 |
GO:0030145 | manganese ion binding | 6 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0046914 | transition metal ion binding | 5 | 5 |
GO:0070006 | metalloaminopeptidase activity | 6 | 5 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 271 | 273 | PF00675 | 0.416 |
CLV_PCSK_KEX2_1 | 271 | 273 | PF00082 | 0.416 |
CLV_PCSK_PC1ET2_1 | 271 | 273 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.440 |
DOC_CYCLIN_yCln2_LP_2 | 209 | 215 | PF00134 | 0.440 |
DOC_MAPK_gen_1 | 257 | 265 | PF00069 | 0.440 |
DOC_MAPK_MEF2A_6 | 257 | 265 | PF00069 | 0.440 |
DOC_PP4_FxxP_1 | 258 | 261 | PF00568 | 0.523 |
DOC_USP7_MATH_1 | 180 | 184 | PF00917 | 0.440 |
DOC_USP7_MATH_1 | 241 | 245 | PF00917 | 0.407 |
DOC_WW_Pin1_4 | 223 | 228 | PF00397 | 0.440 |
DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.308 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.243 |
LIG_BIR_III_4 | 142 | 146 | PF00653 | 0.440 |
LIG_BRCT_BRCA1_1 | 254 | 258 | PF00533 | 0.440 |
LIG_CtBP_PxDLS_1 | 6 | 12 | PF00389 | 0.352 |
LIG_FHA_1 | 107 | 113 | PF00498 | 0.440 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.243 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.440 |
LIG_LIR_Apic_2 | 221 | 227 | PF02991 | 0.440 |
LIG_LIR_Apic_2 | 255 | 261 | PF02991 | 0.515 |
LIG_LIR_Apic_2 | 32 | 38 | PF02991 | 0.440 |
LIG_LIR_Gen_1 | 98 | 108 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 11 | 17 | PF02991 | 0.527 |
LIG_LIR_Nem_3 | 208 | 214 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 98 | 103 | PF02991 | 0.440 |
LIG_LYPXL_yS_3 | 211 | 214 | PF13949 | 0.440 |
LIG_Pex14_2 | 258 | 262 | PF04695 | 0.527 |
LIG_SH2_CRK | 14 | 18 | PF00017 | 0.440 |
LIG_SH2_CRK | 224 | 228 | PF00017 | 0.440 |
LIG_SH2_CRK | 35 | 39 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 189 | 192 | PF00017 | 0.243 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.440 |
LIG_Sin3_3 | 86 | 93 | PF02671 | 0.440 |
LIG_SUMO_SIM_anti_2 | 125 | 132 | PF11976 | 0.440 |
LIG_SUMO_SIM_anti_2 | 135 | 142 | PF11976 | 0.320 |
LIG_TYR_ITIM | 209 | 214 | PF00017 | 0.440 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.515 |
MOD_CK1_1 | 237 | 243 | PF00069 | 0.440 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.440 |
MOD_CK2_1 | 188 | 194 | PF00069 | 0.440 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.527 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.418 |
MOD_GlcNHglycan | 239 | 242 | PF01048 | 0.492 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.440 |
MOD_GSK3_1 | 236 | 243 | PF00069 | 0.506 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.453 |
MOD_N-GLC_1 | 104 | 109 | PF02516 | 0.440 |
MOD_N-GLC_1 | 38 | 43 | PF02516 | 0.243 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.449 |
MOD_Plk_1 | 104 | 110 | PF00069 | 0.440 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.243 |
MOD_ProDKin_1 | 223 | 229 | PF00069 | 0.440 |
MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.308 |
MOD_SUMO_for_1 | 4 | 7 | PF00179 | 0.375 |
TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 211 | 214 | PF00928 | 0.440 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8ICD9 | Leishmania donovani | 91% | 96% |
A4HUX2 | Leishmania infantum | 91% | 96% |
Q4QH18 | Leishmania major | 91% | 100% |